OPKO HEALTH, INC. (OPK)
Preclinical Data for OPKO Biologics OPK8801001 in Acromegaly Presented at ENDO 2026
Preclinical Data for OPKO Biologics OPK8801001 in Acromegaly Presented at ENDO 2026
Similarweb Secures Multi-Year, Seven-Figure ARR Contracts Worth Approximately $47 Million in Total Contract Value
Sunrise Realty Trust Announces Dividend for the Second Quarter 2026
Wolfspeed Appoints Seasoned Investor Relations Leader to Enhance Engagement with the Investment Community
Iveda Introduces High-Precision Real-Time Location Upgrade with 10cm Accuracy and New AoA Sensors
Meat is the Make-or-Break Factor in Sandwich Satisfaction, New Survey Finds
Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
MSCI Publishes Investor Presentation
Chaince Digital Announces Launch of USDC Yield Vault on Morpho Curated by AlphaPing
Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller